Metabolic alterations and chronic hepatitis C: treatment strategies.
about
NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic ManifestationsHepatitis C virus and neurological damageType 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the SpotlightGenetic, metabolic and environmental factors involved in the development of liver cirrhosis in MexicoPathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogenHepatitis C virus genotype 6: virology, epidemiology, genetic variation and clinical implicationFatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIVChronic hepatitis C virus infection and neurological and psychiatric disorders: an overviewInsulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progressionFunctional implications of mitochondrial reactive oxygen species generated by oncogenic virusesA novel small-molecule inhibitor of hepatitis C virus replication acts by suppressing signal transducer and activator of transcription 3.Metabolic disorders and steatosis in patients with chronic hepatitis C: metabolic strategies for antiviral treatments.HOMA-AD in Assessing Insulin Resistance in Lean Noncirrhotic HCV Outpatients.Effects of lifestyle changes including specific dietary intervention and physical activity in the management of patients with chronic hepatitis C--a randomized trial.Retrospective study of the associations between hepatitis C virus infection and metabolic factors.The AMPK-related kinase SNARK regulates hepatitis C virus replication and pathogenesis through enhancement of TGF-β signaling.Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanismsA Different Perspective for Management of Diabetes Mellitus: Controlling Viral Liver DiseasesHCV and oxidative stress in the liver.The predictive value of steatosis in hepatitis C virus infection.Hepatitis C and lipid metabolism, hepatic steatosis, and NAFLD: still important in the era of direct acting antiviral therapy?Mitochondrial dysfunctions and altered metals homeostasis: new weapons to counteract HCV-related oxidative stress.The potential of signal peptide peptidase as a therapeutic target for hepatitis C.Characterisation of the cytokine milieu associated with the up-regulation of IL-6 and suppressor of cytokine 3 in chronic hepatitis C treatment non-responders.Age and gender differences in the relationship between hepatitis C infection and all stages of Chronic kidney disease.Association between the hepatitis B and C viruses and metabolic diseases in patients stratified by age.Structural Proteins of HCV and Biological Functions
P2860
Q26745576-A2F86EDB-ECBB-45E3-84BC-40562F2A2E50Q26748575-8F2EAF55-4113-495B-82F2-CFFD17817447Q26752583-B67DF0FF-5F0A-44D2-8501-FA4C4714DC9DQ26778035-DA7322A7-0134-4A9E-8EA3-A696D02F5F8FQ26861095-46CE6F1E-8F40-475F-B6CA-D320E1DABF30Q27024231-56E1FF4D-67C3-4867-B423-496666249BF9Q28079826-AD144CE9-2177-469C-ADFA-C5D9A2328FF8Q28082212-60F62D0E-46DB-46F4-B5B1-EB4697A72C95Q34263370-2D629A8F-F38E-4D39-816D-94159CF66139Q34856882-45E8E6B1-69B0-493D-8EA7-20ED785B2F6BQ35598686-C40401C5-6E9C-464A-B4C5-7A4FE2DDA9F4Q36026554-C94D9261-C6A0-41EF-A8C5-603541E7B18AQ36118843-6E8EC4A5-43DA-423F-87FB-993DB55DDD6CQ37115792-F310DB27-4B57-4337-9E61-5A2A04A168ABQ37374053-22E9C559-93C5-44FE-9DFD-3551B245EB33Q37400658-E578B27E-ECDE-4A8C-9A5B-43EA2B920503Q37682486-1D57A3E8-18A8-411D-B916-74F0E948D508Q37703437-E513612F-769D-44CF-92BA-422975AC6AC6Q38077447-77309CEF-0C02-4D10-9082-0EDE94D34A1FQ38085061-A7779C4C-4029-4281-8160-FEF426584978Q38170504-F8C13B8E-3C00-4B9E-9C28-9960A505A3E0Q38174062-B074B26B-07D9-47A5-A34D-0706E7712876Q40078310-3EA91540-C07B-41DA-9028-B6F95272987DQ42241367-217AC0E6-CC46-41B2-BEA0-DA486F369AC2Q42251188-ECAA9C6B-354B-4E73-961D-52C19EE2B7A9Q50894454-FA88A5BE-F578-4062-A6C6-FB0E51C373B4Q57064243-1A8D8516-563D-4A6A-91CD-9C03C879CE98
P2860
Metabolic alterations and chronic hepatitis C: treatment strategies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Metabolic alterations and chronic hepatitis C: treatment strategies.
@en
Metabolic alterations and chronic hepatitis C: treatment strategies.
@nl
type
label
Metabolic alterations and chronic hepatitis C: treatment strategies.
@en
Metabolic alterations and chronic hepatitis C: treatment strategies.
@nl
prefLabel
Metabolic alterations and chronic hepatitis C: treatment strategies.
@en
Metabolic alterations and chronic hepatitis C: treatment strategies.
@nl
P2093
P2860
P1476
Metabolic alterations and chronic hepatitis C: treatment strategies.
@en
P2093
Luciano Restivo
Luigi E Adinolfi
Paola Loria
P2860
P304
P356
10.1517/14656566.2011.597742
P407
P577
2011-09-02T00:00:00Z